Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort

First, to evaluate outcome, the benefit of concurrent chemotherapy and prognostic factors in a cohort of sixty-four high-grade glioma patients who underwent a second course of radiation therapy at progression. Second, to validate a new prognostic score for overall survival after reirradiation of pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Scholtyssek, Felix (Author) , Zwiener, Isabella (Author) , Schlamann, Annika (Author) , Seidel, Clemens (Author) , Meixensberger, Jürgen (Author) , Bauer, Manfred (Author) , Hoffmann, Karl-Titus (Author) , Combs, Stephanie (Author) , von Bueren, André O. (Author) , Kortmann, Rolf-Dieter (Author) , Müller, Klaus (Author)
Format: Article (Journal)
Language:English
Published: 3 July 2013
In: Radiation oncology
Year: 2013, Volume: 8, Pages: 1-9
ISSN:1748-717X
DOI:10.1186/1748-717X-8-161
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1748-717X-8-161
Get full text
Author Notes:Felix Scholtyssek, Isabella Zwiener, Annika Schlamann, Clemens Seidel, Jürgen Meixensberger, Manfred Bauer, Karl-Titus Hoffmann, Stephanie E. Combs, André O. von Bueren, Rolf-Dieter Kortmann and Klaus Müller
Description
Summary:First, to evaluate outcome, the benefit of concurrent chemotherapy and prognostic factors in a cohort of sixty-four high-grade glioma patients who underwent a second course of radiation therapy at progression. Second, to validate a new prognostic score for overall survival after reirradiation of progressive gliomas with an independent patient cohort.
Item Description:Gesehen am 15.07.2021
Physical Description:Online Resource
ISSN:1748-717X
DOI:10.1186/1748-717X-8-161